These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pulse therapy. Therapeutic efficacy in the treatment of pyoderma gangrenosum. Johnson RB; Lazarus GS Arch Dermatol; 1982 Feb; 118(2):76-84. PubMed ID: 7036913 [No Abstract] [Full Text] [Related]
7. Malignant pyoderma or pyoderma gangrenosum of the head and neck? Wernikoff S; Merritt C; Briggaman RA; Woodley DT Arch Dermatol; 1987 Mar; 123(3):371-5. PubMed ID: 3813604 [TBL] [Abstract][Full Text] [Related]
8. Hyperimmunoglobulin E and impaired neutrophil functions in a case of pyoderma gangrenosum: effect of clofazimine. Berbis P; Mege JL; Capo C; Kaplanski S; Bongrand P; Privat Y J Am Acad Dermatol; 1988 Mar; 18(3):574-6. PubMed ID: 3351016 [No Abstract] [Full Text] [Related]
9. The current status of pyoderma gangrenosum. Holt PJ Clin Exp Dermatol; 1979 Dec; 4(4):509-16. PubMed ID: 394888 [No Abstract] [Full Text] [Related]
10. Pharmacological modulation of neutrophil phagocytic function in a patient with recurrent sepsis, pyoderma gangrenosum and impaired phagocytosis. Bentley-Phillips CB; Cooper RC; Hallett AF Br J Dermatol; 1982 Jun; 106(6):687-95. PubMed ID: 7082573 [TBL] [Abstract][Full Text] [Related]
11. Pyoderma gangrenosum associated with active chronic hepatitis: report of two cases. Byrne JP; Hewitt M; Summerly R Arch Dermatol; 1976 Sep; 112(9):1297-301. PubMed ID: 999311 [TBL] [Abstract][Full Text] [Related]
12. Treatment of pyoderma gangrenosum with methotrexate. Teitel AD Cutis; 1996 May; 57(5):326-8. PubMed ID: 8726713 [TBL] [Abstract][Full Text] [Related]
13. Pyoderma gangrenosum in a patient with autoimmune haemolytic anaemia and complement deficiency. Coors EA; von den Driesch P Br J Dermatol; 2000 Jul; 143(1):154-6. PubMed ID: 10886151 [TBL] [Abstract][Full Text] [Related]